ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Function-oriented synthesis of Imidazo[1,2-a]pyrazine and Imidazo[1,2-b] pyridazine derivatives as potent PI3K/mTOR dual inhibitors

Li, Chuchu; Han, Yuqiao; Wang, Zhengyang; Yu, Yanan; Wang, Chen; Ren, Ziwei; Guo, Yanzhi; Zhu, Tong; Li, XuWen*; Dong, Suzhen*; Ma, Mingliang*中国科学院
European Journal of Medicinal Chemistry2023-2-5DOI: 10.1016/j.ejmech.2022.115030
2被引7阅读
引用收藏
分享

摘要

The PI3K-Akt-mTOR signaling pathway is a highly frequently activated signal transduction pathway in human malignancies, which has been a hot target for anti-tumoral drug discovery. Based on our previous research, a function-oriented synthesis (FOS) of imidazo[1,2-a]pyrazines and imidazo[1,2-b]pyridazines was conducted, and their anticancer activities in vitro and in vivo were evaluated. Among them, compound 42 exhibited excellent dual PI3K/mTOR inhibitory activity, with IC50 values on PI3K alpha and mTOR of 0.06 nM and 3.12 nM, respectively, much better than our previous reported compound 15a. Furthermore, compound 42 exhibited significant in vitro and in vivo anti-tumoral activities, great kinase selectivity, low hepatotoxicity, modest plasma clearance and acceptable oral bioavailability, which is a promising PI3K/mTOR targeted anti-cancer drug candidate.

学科与关键词

关键词
PI3KmTOR dual inhibitorsCancerAntitumor activityHepatotoxicity
相关
加载中…
  • Design, synthesis and bioevaluation of novel substituted triazines as potential dual PI3K/mTOR inhibitors
    Wu, Ting-Ting; Guo, Qing-Qing; Chen, Zi-Li; Wang, Li-Li; Du, Yao; Chen, Rui; Mao, Yuan-Hu; Yang, Sheng-Gang; Huang, Jing; Wang, Jian-Ta; Wang, Ling; Tang, Lei*; Zhang, Ji-Quan*European Journal of Medicinal Chemistry, 2020, 204: 112637.被引 26
  • Design, synthesis and pharmacological evaluation of 2-arylurea-1,3,5-tria-zine derivative (XIN-9): A novel potent dual PI3K/mTOR inhibitor for cancer therapy
    Sun, Xin; Zhang, Binliang; Luo, Leixuan; Yang, Yang; He, Bin; Zhang, Qian; Wang, Linxiao; Xu, Shan*; Zheng, Pengwu*; Zhu, Wufu*Bioorganic Chemistry, 2022, 129: 106157.被引 10
  • Design, synthesis and pharmacological evaluation of 2-arylurea-1,3,5-triazine derivative (XIN-9): A novel potent dual PI3K/mTOR inhibitor for cancer therapy (vol 129, 106157, 2022 )
    Sun, Xin; Zhang, Binliang; Luo, Leixuan; Yang, Yang; He, Bin; Zhang, Qian; Wang, Linxiao; Xu, Shan*; Zheng, Pengwu*; Zhu, Wufu*Bioorganic Chemistry, 2023, 131: 106336.
查看全部 →

发表信息

论文状态
公开发表
期刊
European Journal of Medicinal Chemistry
发表日期
2023-02-05
卷期
第 247 卷
页码
115030
DOI
10.1016/j.ejmech.2022.115030
语言
MULTI-LANGUAGE
成果收录
SCIE
资助标注
Fundamental Research Funds for the Central Universities; Natural Science Foundation of China [82022069]

作者

  • L

    Li, Chuchu (第一作者)

    new · chinese acad sci · shanghai inst mat med

  • H

    Han, Yuqiao

    new

查看全部 11 位作者收起作者
  • W

    Wang, Zhengyang

    new

  • Y

    Yu, Yanan

    new

  • W

    Wang, Chen

    shanghai univ engn sci

  • R

    Ren, Ziwei

    new

  • G

    Guo, Yanzhi

    new

  • Z

    Zhu, Tong

    new

  • L

    Li, XuWen (通讯)

    chinese acad sci · shanghai inst mat med

  • D

    Dong, Suzhen (通讯)

    new

  • M

    Ma, Mingliang (通讯)

    new

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417